CLASS II Device recall · Reported 30 Sep 2020 · FDA Enforcement Report

DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage recalled

Beckman Coulter Biomedical is recalling DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage, distributed nationwide in the US. The recall was initiated on 17 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial/Lot Number(s)/Software Version: all
Quantity recalled32 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2983-2020
FDA event ID
85874
Recalling firm
Beckman Coulter Biomedical, Munich, N/A
Classification
Class II
Status
Terminated
Recall initiated
17 Jun 2020
FDA classified
18 Sep 2020
Reported
30 Sep 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

17 Jun 2020Recall initiated by company
18 Sep 2020Classified by FDA+93 days
30 Sep 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The DxA 5000 instructions for use may be confusing regarding the re-use of sample IDs. Beckman Coulter has received complaints where the re-use of sample barcodes were not being detected by the system .

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage: The DxA 5000 is a high-speed, modular, automated sample handling system that performs pre-analytical and post-analytical sample processing and storage. The automation system also sorts, routes, and presents sample tubes to analyzers for analysis. The DxA 5000 also consolidates a variety of analytical instruments, such as an Immunoassay analyzer, into a unified workstation on a track system.

Where it was distributed

Worldwide distribution - US Nationwide distribution including in the states of Illinois, Ohio, Pennsylvania, and West Virginia. The countries of Australia, Canada, China, Czech Republic, France, Israel, Italy, Germany, Switzerland, Spain, Netherlands, and United Kingdom.

Nationwide IllinoisOhioPennsylvaniaWest Virginia

Questions about this recall

Why was it recalled?

The DxA 5000 instructions for use may be confusing regarding the re-use of sample IDs. Beckman Coulter has received complaints where the re-use of sample barcodes were not being detected by the system .

Which lots are affected?

Serial/Lot Number(s)/Software Version: all

Where was it sold?

Worldwide distribution - US Nationwide distribution including in the states of Illinois, Ohio, Pennsylvania, and West Virginia. The countries of Australia, Canada, China, Czech Republic, France, Israel, Italy, Germany, Switzerland, Spain, Netherlands, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter Biomedical

All 7

Other Test Kits & Diagnostics recalls

All 2,656